Given that cutaneous T-cell lymphoma shares symptoms with many other ... During diagnosis, your healthcare provider will also determine the stage of your disease, which is crucial for developing ...

Pembrolizumab shows clinical promise as a treatment for mycosis fungoides and Sézary syndrome, achieving a response in nearly ...

The reactive T cells then exit the skin, re-enter the lymphatic or vascular spaces, and recirculate or undergo the process of natural cell death ... in the earliest stages because it mimics ...

Investigators found that denileukin diftitox, which targets the interleukin-2 receptor, achieves objective response rates in 44% of patients with cutaneous T-cell lymphoma, with a median duration ...

But doctors have many tools in their toolboxes, including medicines and other therapies, to treat all stages of this ... Sometimes mantle cell lymphoma doesn’t respond to treatment, or the ...

The randomised, placebo-controlled FLASH2 trial is expected to enrol nearly 80 patients with early-stage CTCL ... begins enrolling subjects in cutaneous T-cell lymphoma treatment trial" was ...

Clinical-stage oncology company Prescient Therapeutics Ltd has opened the first clinical site for its Phase 2a study of ...

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...